sec filing
RA
NASDAQ · RARE
Ultragenyx Pharmaceutical Inc.
Healthcare · Biotechnology
$14.90
Up+$0.27 (+1.81%)
Updated Oct 15, 2026, 11:27 PM
SID Score
4.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.49B
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $12.73 – $39.89
- Volume
- 2.96M
- Avg. volume
- 1.5M
Price performance · RARE
RARE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
RARE closed at $14.90 after 21 trading sessions, up 15.68% for the selected period.
- Last close
- $14.90
- Period change
- +15.68%
- Period low
- $12.88
- Period high
- $15.62
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $14.93 | $15.18 | $14.67 | $14.90 | 2.96M |
| Oct 13, 2026 | $15.27 | $15.39 | $14.69 | $14.92 | 5.31M |
| Oct 12, 2026 | $15.42 | $15.49 | $15.10 | $15.30 | 2.9M |
| Oct 9, 2026 | $15.30 | $15.73 | $15.23 | $15.48 | 2.93M |
| Oct 8, 2026 | $14.79 | $15.52 | $14.43 | $15.29 | 5.4M |
| Oct 7, 2026 | $14.37 | $15.2532 | $14.345 | $14.89 | 4.16M |
| Oct 6, 2026 | $14.60 | $14.70 | $14.08 | $14.46 | 3.89M |
| Oct 5, 2026 | $15.25 | $15.31 | $14.21 | $14.50 | 4.66M |
| Oct 2, 2026 | $14.90 | $15.28 | $14.67 | $15.22 | 3.88M |
| Oct 1, 2026 | $15.03 | $15.25 | $14.62 | $14.75 | 4.12M |
| Sep 30, 2026 | $15.475 | $15.53 | $14.86 | $15.03 | 4.42M |
| Sep 29, 2026 | $14.455 | $15.50 | $14.11 | $15.32 | 5.88M |
| Sep 28, 2026 | $14.33 | $14.47 | $14.11 | $14.41 | 4.94M |
| Sep 25, 2026 | $14.87 | $14.94 | $14.1508 | $14.50 | 4.31M |
| Sep 24, 2026 | $14.73 | $14.87 | $14.545 | $14.77 | 3.49M |
| Sep 23, 2026 | $15.40 | $15.4979 | $14.54 | $14.88 | 5.71M |
| Sep 22, 2026 | $14.78 | $16.12 | $14.475 | $15.615 | 8.13M |
| Sep 21, 2026 | $14.58 | $15.01 | $14.275 | $14.65 | 5.27M |
| Sep 18, 2026 | $14.79 | $15.07 | $14.07 | $14.51 | 13.34M |
| Sep 17, 2026 | $13.22 | $14.575 | $13.20 | $14.50 | 12.43M |
| Sep 16, 2026 | $13.07 | $13.22 | $12.73 | $12.88 | 5.03M |
Latest RARE news
The latest Smart Investors Daily articles mentioning RARE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

